Blog
IOM report responds to Duke research, calls for greater “omics” oversight
In the wake of the recent commotion surrounding flawed research at Duke University on diagnostic tools based on molecular patterns (“omics” tests), an Institute of Medicine (IOM) panel has issued a report entitled Evolution of Translational Omics: Lessons Learned and...
FDA issues warning letter to clinical investigator studying marketed drugs
FDA recently issued a warning letter to clinical investigator Betty Tuller, PhD, after she purportedly violated several requirements under 21 CFR Part 312 while working at Florida Atlantic University’s Center for Complex Systems and Brain Sciences. According to the...
St. Vincent’s Health to hold Eighth Annual Research Symposium
Save the date Wednesday June 13, 2012 for the Eighth Annual Research Symposium by St. Vincent Health. The event will go from 7:00am-4:00pm at the Lilly Conference Center at the Marten House. The main topics will be regulatory updates, family medicine, women's...
Case Studies Released
Pearl is excited to announce its release of several case studies. Check out our case study section to see how Pearl offers real solutions to companies ranging from small start-ups to large multi-nationals. To view our IRB case studes, click here. To see the breadth...
INpact Meeting April 20th
Please join us for the April 20th, 2012 INpact meeting from 11:30AM-1:00PM in Indianapolis, Indiana. Gretchen Bowker, Pearl Pathways COO, will serve as a panelist for the discussion. The topic of discussion will be about the FDA 510(k) process and how it will change...